Pay in 4 interest-free payments of $6.44 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
[Our] basic thinking on AOD9604 is that the drug failed because it was made orally available, which likely reduced bioavailability and also potentially resulted in protein denaturisation in the gastrointestinal tract, which would have reduced the drugs activity
Frequency: Monthly or as indicated by lab results
Route: Intramuscular (IM) or subcutaneous (SubQ)
The clinic matters more than the molecule: sourcing, candidacy screening, and monitoring are what separate responsible care from an online purchase
It's one of the most frequently submitted drug codes alongside 96372, and it's also one of the most frequently denied under Medicare when the diagnosis doesn't meet LCD criteria
Nerve symptoms can take longer and neurological damage is difficult to reverse. Can B12 Cause Side Effects
